Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health,…

AffyImmune Therapeutics Announces Hiring of Matt Britz as Senior Vice President of Business Development

AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR-T cells…

Behavioural/Mental Health Software Market worth $4.9 billion by 2026 – Exclusive Report by MarketsandMarkets™

According to the new market research report “Behavioural/Mental Health Software Market by Component (Services, Software), Delivery (Subscription, Ownership),…

Global Dental Scalers Market- Beyes Dental Canada Inc., Brasseler USA, COLTENE Holding AG, Among Others to Contribute to the Market Growth

The Dental Scalers Market report has been added to Technavio’s offering. With over 500 specialized analysts, Technavio’s report library…

Digital Diagnostics and Orbis International announce study to help save sight in Bangladesh

Digital Diagnostics, developers of IDx-DR, an FDA De Novo-cleared autonomous AI system for the detection of diabetic…

Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434

Product candidate FPI-1434, administered at three different dose levels, demonstrated a favorable safety profile with no…

Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data…

Model Suggests Surgery Should Come Before Chemotherapy for Select Patients with Aggressive Ovarian Cancer

Certain patients with an aggressive form of ovarian cancer have a better chance of a cure…

ACT Against COVID

 ACT Against COVID: The Alliance for Comprehensive Testing (ACT) today announced an effort to improve public…

Mnemo Therapeutics Announces €75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform

Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, stronger…